Melatonin in autism spectrum disorders
- PMID: 24050742
- DOI: 10.2174/15748847113086660072
Melatonin in autism spectrum disorders
Abstract
Melatonin is an endogenous neurohormone produced predominantly in the pineal gland. Recent studies have implicated abnormalities in melatonin physiology and the circadian rhythm in individuals with autism spectrum disorders (ASD). These physiological abnormalities include lower nighttime melatonin or melatonin metabolite concentrations in ASD compared to controls. These abnormalities in melatonin concentrations may be directly attributed to variations in melatonin pathway physiology as both functional and genetic variations in this pathway have been reported in children with ASD. Four studies have observed a correlation between abnormal melatonin concentrations and the severity of autistic behaviors. Twenty clinical studies have reported improvements in sleep parameters with exogenous melatonin supplementation in ASD, including longer sleep duration, less nighttime awakenings and quicker sleep onset. A recent meta-analysis of five randomized, double-blind, placebo-controlled crossover trials examining exogenous melatonin supplementation in ASD reported significant improvements with large effect sizes in total sleep duration and sleep onset latency compared to both baseline and placebo. Six studies reported that the nighttime administration of exogenous melatonin was associated with better daytime behaviors. Four studies reported improvements with exogenous melatonin supplementation when other sleep medications had previously failed. Adverse effects of melatonin were minimal to none in the twenty treatment studies. These studies indicate that the administration of exogenous melatonin for abnormal sleep parameters in ASD is evidence-based. Further studies examining optimal effective dosing and timing of dosing are warranted.
Similar articles
-
Melatonin in autism spectrum disorders: a systematic review and meta-analysis.Dev Med Child Neurol. 2011 Sep;53(9):783-792. doi: 10.1111/j.1469-8749.2011.03980.x. Epub 2011 Apr 19. Dev Med Child Neurol. 2011. PMID: 21518346 Review.
-
[Therapeutic approaches for sleep and rhythms disorders in children with ASD].Encephale. 2022 Jun;48(3):294-303. doi: 10.1016/j.encep.2021.08.005. Epub 2022 Feb 1. Encephale. 2022. PMID: 35120753 Clinical Trial. French.
-
Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans.Int J Mol Sci. 2017 Jun 20;18(6):1314. doi: 10.3390/ijms18061314. Int J Mol Sci. 2017. PMID: 28632163 Free PMC article. Review.
-
Melatonin for disordered sleep in individuals with autism spectrum disorders: systematic review and discussion.Sleep Med Rev. 2011 Dec;15(6):379-87. doi: 10.1016/j.smrv.2011.02.001. Epub 2011 Mar 9. Sleep Med Rev. 2011. PMID: 21393033 Review.
-
A review of sleep disorders and melatonin.Neurol Res. 2017 Jun;39(6):559-565. doi: 10.1080/01616412.2017.1315864. Epub 2017 May 1. Neurol Res. 2017. PMID: 28460563 Review.
Cited by
-
Melatonin as a Mediator of the Gut Microbiota-Host Interaction: Implications for Health and Disease.Antioxidants (Basel). 2023 Dec 23;13(1):34. doi: 10.3390/antiox13010034. Antioxidants (Basel). 2023. PMID: 38247459 Free PMC article. Review.
-
Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder.Front Neurosci. 2023 Jun 16;17:1185737. doi: 10.3389/fnins.2023.1185737. eCollection 2023. Front Neurosci. 2023. PMID: 37397463 Free PMC article.
-
Age-Related Effects of Exogenous Melatonin on Anxiety-like Behavior in C57/B6J Mice.Biomedicines. 2023 Jun 13;11(6):1705. doi: 10.3390/biomedicines11061705. Biomedicines. 2023. PMID: 37371801 Free PMC article.
-
Chronic Administration of Melatonin: Physiological and Clinical Considerations.Neurol Int. 2023 Mar 15;15(1):518-533. doi: 10.3390/neurolint15010031. Neurol Int. 2023. PMID: 36976674 Free PMC article. Review.
-
Sleep Problems, Circadian Rhythms, and Their Relation to Behavioral Difficulties in Children and Adolescents with Autism Spectrum Disorder.J Autism Dev Disord. 2024 May;54(5):1712-1726. doi: 10.1007/s10803-023-05934-7. Epub 2023 Mar 4. J Autism Dev Disord. 2024. PMID: 36869970 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical